Stephen Kinnock MP: speeches

Speeches

• 3 Sept 2025 · Maternity Care · Hansard source

  More

  My hon. Friend is campaigning strongly for her constituents on this issue. We are establishing the maternity and neonatal national taskforce, which will develop a national plan to drive improvements across maternity and neonatal care. It will be chaired by my right hon. Friend the Secretary of State for Health and Social Care and made up of a panel of experts, and family, charity and staff representatives. I was pleased to learn that my hon. Friend met Baroness Merron in June to discuss maternity care in Luton North.

• 3 Sept 2025 · Maternity Care · Hansard source

  More

  I will absolutely raise the issue with colleagues in the Department and we will write to the hon. Lady urgently with the answers she is looking for.

• 3 Sept 2025 · Maternity Care · Hansard source

  More

  My hon. Friend is a strong campaigner on this issue for his constituents. The Care Quality Commission has committed to monitoring maternity services at Bedford hospitals closely, including through further inspections, to ensure that people receive safe care while improvements are implemented. The investigation will seek to understand the systemic issues behind why so many women, babies and families experience unacceptable care. The chair is working with families to finalise the terms of reference for the investigations and those will be published shortly.

• 3 Sept 2025 · Maternity Care · Hansard source

  More

  I agree that it is vital to listen to those voices; it will not be possible to get to the bottom of why care is not of an acceptable standard without hearing those voices. I have heard what the hon. Lady has said about Donna Ockenden and I will certainly take that away to discuss with ministerial colleagues.

• 2 Sept 2025 · Eating Disorders: Prevention of Deaths · Hansard source

  More

  Can I come back to the hon. Gentleman on that? I will double-check. My understanding was that this was for both. My notes do say “for adult eating disorder services”, but my understanding was that this was a holistic process that would include children and schools. I will come back to him to confirm that point, so apologies if that is not entirely clear. Actually, I am sorry—it is next in my comments. NHS England is also producing updated national guidance for eating disorders in children and young people. That will reflect the full range of eating disorders in children and young people, and the treatment options available to CYP and their families to address them. It will focus on early identification and intervention, community treatment and support, and it will highlight the importance of integrating schools, colleges and primary care to improve support. Before the hon. Gentleman intervenes, he will have noted, as I have, that there is no specific date for that, so I will come back to him on that. The adult one will be before 1 January. I would like to address the very serious concerns that have been raised about reports of people with eating disorders being offered end-of-life care. Let me be absolutely clear: these reports are deeply troubling, and I acknowledge the distress that they will have caused to families and all those affected by eating disorders. The Royal College of Psychiatrists has been crystal clear that eating disorders are not terminal illnesses. It has updated its guidance to re-emphasise that important point, so that no person, nor their loved ones, should ever feel that treatment has reached a point of no return. NHS England is clear that all those with severe, complex or long-standing eating disorders should have access to eating disorder services, including hospital care when needed. A personal recovery model, with a focus on harm minimisation, symptom management and quality of life, is well established in providing hope and opportunities for recovery for many people with eating disorders. English law provides a robust framework for safeguarding a patient’s best interests. I assure hon. Members that we take these concerns very seriously. We will continue to work with clinicians, NHS England and families to ensure that the highest standards of care are upheld, and that every person is given hope and support in their recovery. Hon. Members have raised how those with eating disorders are disproportionately at risk of self-harm or suicide. The national suicide prevention strategy has highlighted the increased risk, and is committed to working with policy, clinical and personal experience experts to explore bespoke suicide prevention activity when needed. Specialists in eating disorders must ensure that they take a holistic approach to eating disorder treatment, and ensure that they are not likely to inadvertently increase the risk of suicide. Several hon. Members, as well as the APPG report published in January this year, have raised the creation of a national register for eating disorder deaths, and the holding of a confidential inquiry into all eating disorder deaths. I reassure colleagues that the Department of Health and Social Care is wholeheartedly committed to learning from deaths, in order to prevent future tragedies and to improve quality of care. The Department receives and responds to prevention of future deaths—PFD—notices relating to eating disorders, and it uses that work to inform practice going forward. For example, the medical emergencies in eating disorders—MEED—guidance was created following a coroner’s report and has since been rolled out nationwide. This Government are determined to focus funding directly to frontline services, in order to best support those currently struggling with this deadly illness. Similarly, we share the concerns that have been raised about eating disorder deaths not being accurately recorded. It is vital that the extent to which eating disorders have caused or contributed to deaths is properly known. That matter is currently being explored with the national medical examiner for England and Wales, the Office for National Statistics and the Coroners’ Society of England and Wales. To draw my remarks to a close, I would like to thank all the hon. Members here today. The fact that the debate was so well attended reflects how important the issue is to all of us and our constituents. The service that we provide can often be a matter of life and death. We are all very conscious of the gravity of the responsibility that we hold in that context. I thank all those in attendance for advocating for their constituents and all those across the country who have been affected by an eating disorder.

• 2 Sept 2025 · Eating Disorders: Prevention of Deaths · Hansard source

  More

  I absolutely will; that is just coming up in my comments. I am not sure that the shadow Minister will be satisfied with the answer, but I will refer precisely to the question that he is asking. The MHSTs will continue to provide assistance to school staff in raising staff understanding, recognition and awareness of eating disorders, ensuring that they can provide crucial early intervention for children at risk. Early intervention is also a priority for adults with eating disorders, as set out in the NHS’s adult community mental health framework. NHS England has established 15 provider collaboratives focusing on adult eating disorders. Those collaboratives are working to redesign care pathways and focus resources on community services. By providing treatment earlier and closer to home, we will see better outcomes for adults with eating disorders and their families. Turning to the guidance, which a number of hon. Members, including the shadow Minister, have raised, we are producing updated guidance to help services to implement those transformations. NHS England first published guidance in 2019 for adult eating disorder services to ensure that they are integrated with day-patient services or in-patient care. A new service specification for adult eating disorder in-patient provision has been through a public consultation and will progress to publication this year. So I can guarantee that it will be published before 1 January, but I cannot give the shadow Minister a precise date.

• 2 Sept 2025 · Eating Disorders: Prevention of Deaths · Hansard source

  More

  It is a pleasure to serve under your chairship, Sir Desmond. I begin by congratulating my hon. Friend the Member for Isle of Wight West (Mr Quigley) on securing today’s debate and speaking so bravely and movingly about his family. I pay tribute to his work in the all-party parliamentary group on eating disorders, and I know that he and many other hon. Members present have worked tirelessly to advocate for those with eating disorders. Every death from an eating disorder is a tragedy. We have heard from hon. Members about the devastating effect of these conditions, both for patients and their loved ones. But we must be clear that eating disorders are not terminal illnesses. With the right treatment and support, recovery is possible. Many across the Chamber have made that point, and I pay tribute to everyone who has contributed so powerfully. I also congratulate Arek and Claudia, who I know made outstanding contributions to drafting the speech made by my hon. Friend the Member for Beckenham and Penge (Liam Conlon). Through the 10-year health plan, the Government will ensure that those living with eating disorders are given the support they need. We will cut waiting times and ensure that people can access treatment and support earlier. Improving eating disorder services is a priority for the Government, and a fundamental part of our work to transform mental health services. Last financial year, we provided £106 million in funding for children’s eating disorder services, an increase of £10 million since 2023-24. That increase in funding is helping our clinicians to support more people, and to change and save lives.

• 2 Sept 2025 · Eating Disorders: Prevention of Deaths · Hansard source

  More

  I will come on to talk about the guidance that is being produced. There is a risk that we can end up with a proliferation of documents, strategies and plans. Our view is that the more streamlined we are and the clearer the lines of accountability, the better the performance becomes. We are committed to the guidance, and I will talk a bit about that, but we are not convinced that having strategies alongside guidance, plans and other documents will help the process. Members here will be well aware of the increase in the prevalence of mental health conditions, including eating disorders, since the pandemic. The increase in demand has placed significant pressure on services, but the extra funding is making a difference. The latest quarterly figures from NHS mental health services monthly statistics show that, between April and June 2025, 3,138 children successfully entered treatment in community eating disorder services. That is the highest figure on record since NHS England began collecting this data in 2021. At the same time, waiting lists to begin routine eating disorder treatment have shortened by 20% from the year before. NHS England has also commissioned the Royal College of Psychiatrists to carry out a national audit of eating disorders. That audit is collecting data on eating disorders across community and in-patient settings to drive improvements in the identification and treatment of eating disorders. The audit will monitor how services are performing against standards, and highlight any inequalities in access to care. That will help services to provide safe, effective, patient-centred, timely, efficient and equitable care. In addition to improved services for the treatment of eating disorders, we are also working to tackle their underlying causes. In particular, we are deeply concerned about harmful online content that promotes negative body image, harmful eating behaviours, suicide or self-harm to those who are most vulnerable. The Online Safety Act 2023 has now come into force and delivers on our commitment to make the United Kingdom the safest place to be online. By now, all sites with a significant user base in this country are required to have conducted children’s access and risk assessments, and to follow the new children’s safety codes to prevent them from accessing harmful content, such as promotion of eating disorders. Ofcom now has the ability to investigate or carry out enforcement action against any site that will not abide by those codes. Hon. Members today have raised the need for early intervention to lower the numbers of hospital admissions from eating disorders. We know that the earlier the treatment is provided, the better the chance of recovery, and we are committed to ensuring that everyone with an eating disorder can access specialist help. As part of our mission to build an NHS that is fit for the future, there is a critical need to shift the treatment of eating disorders from hospital to community, including children’s community eating disorder services, crisis care services and intensive day-hospital or home-treatment services. Improved care in the community will give young people early access to evidence-based treatment involving families and carers, thereby improving outcomes and preventing relapse. By preventing eating disorders from progressing into adulthood, we will build on our aim of raising the healthiest generation of children. We have also committed to expanding mental health support teams to reach full coverage in England. To date, we have expanded MHSTs to 52% of pupils; they are working hard in schools to support staff and students alike in meeting the mental health needs of children.

• 2 Sept 2025 · Eating Disorders: Prevention of Deaths · Hansard source

  More

  I agree that Healthwatch did some important work, but what we are doing is changing the culture of how our NHS works. As the hon. Gentleman will have seen, we are abolishing NHS England. That is of a piece with our belief that proper leadership, proper accountability and proper management of a complex system such as our NHS, and particularly its interaction with ICBs and trusts, is about having a clear line of accountability from the Secretary of State through Ministers into the system and those operating at the coalface. We believe that if more layers are put between, and cut across, those lines of accountability, that does not actually drive better outcomes—it drives poorer performance. That is the approach we are taking to the entire system.

• 22 Jul 2025 · Mental Health Research Funding: Eating Disorders · Hansard source

  More

  We remain in close contact with all our colleagues in all the devolved Administrations. I will certainly be following up with officials as we develop the research programmes that we are working on, and as we integrate eating disorders into the broader work we are doing around mental health. Getting 8,500 more mental health workers and creating Young Futures hubs and mental health crisis centres is just some of the work that this Government are doing on this important issue.

• 22 Jul 2025 · Mental Health Research Funding: Eating Disorders · Hansard source

  More

  I know that this subject is close to my hon. Friend’s heart, and I pay tribute to him for his work on it. We recognise the devastating impact that an eating disorder can have, and the earlier the treatment is provided, the greater the chance of recovery. The Department continues to work closely with NHS England, which is now refreshing guidance on children and young people’s eating disorders. I commend the work of Beat, and I would be happy to discuss this further with my hon. Friend.

• 22 Jul 2025 · Mental Health Research Funding: Eating Disorders · Hansard source

  More

  Through the National Institute for Health and Care Research, the Department is committed to finding new ways of tackling eating disorders through research. We are supporting research projects, including the eating disorders genetics initiative—one of the largest studies of its kind—and have a £4.25 million collaboration with other UK research funders to build new partnerships in eating disorder research. We are also strengthening support for people with eating disorders by recruiting more mental health workers, expanding mental health support in schools and embedding it in young futures hubs.

• 22 Jul 2025 · Neighbourhood Health Centre: Long Crendon · Hansard source

  More

  The hon. Member is clearly a doughty campaigner—I am sure that will mean something good will happen for him in the reshuffle that we are all watching with bated breath. I am happy to have that discussion with him. As I said, the neighbourhood health process will be driven primarily by identifying areas where healthy life expectancy is lowest and deprivation is highest. Clearly, he makes a case for his area, and I would be happy to have that discussion with him.

• 22 Jul 2025 · Neighbourhood Health Centre: Long Crendon · Hansard source

  More

  This Government aim to establish a neighbourhood health centre in every community by 2035. We are starting in areas of greatest need where healthy life expectancy is lowest, including rural towns and communities with higher deprivation levels. Planning work has already begun. The hon. Gentleman will know that I updated colleagues yesterday in a “dear colleague” letter around integrated care boards and local authorities being invited to apply to participate in the national neighbourhood health implementation programme.

• 22 Jul 2025 · Urgent Eyecare: East Yorkshire · Hansard source

  More

  The right hon. Member’s constituents can access urgent eyecare services from Hull University teaching hospitals NHS trust 24 hours a day, seven days a week and from a range of high-street optical practices locally. Integrated care boards are responsible for commissioning primary and secondary eyecare services to meet local need. As part of our 10-year plan, we are keen to explore how we can make best use of our primary eyecare workforce as we consider shifting more healthcare into the community.

• 22 Jul 2025 · Urgent Eyecare: East Yorkshire · Hansard source

  More

  I am very sorry to hear of Scott’s experience. What the right hon. Gentleman has outlined is clearly unacceptable. I will absolutely follow up on that issue with officials and report back to him. We cannot allow that sort of poor performance to exist, and those responsible must be held to account.

• 22 Jul 2025 · Topical Questions · Hansard source

  More

  I commend my hon. Friend for bringing his personal experience to bear on this important matter. NHS England’s independent ADHD taskforce is looking at how to provide support for people with ADHD and how to improve it. We are considering the taskforce’s interim report and look forward to the final report later this year. The taskforce is joined up with expert groups established across Government to provide advice on meeting the needs of neurodivergent children and young people in education, and on boosting neurodiversity inclusion at work.

• 22 Jul 2025 · Topical Questions · Hansard source

  More

  We have inherited a system that is utterly failing to meet the needs of children with special educational needs. This Government are reforming the SEND system, ensuring that there is joined-up support across education and healthcare. We are also supporting inclusive environments and earlier intervention for children through the early language support for every child programme, or ELSEC, and the partnership for inclusion of neurodiversity in schools programme, or PINS.

• 22 Jul 2025 · Topical Questions · Hansard source

  More

  This Government are investing an extra £688 million this year to improve access to mental health services. We are transforming our mental health services with 24/7 neighbourhood health centres; I was very pleased last week to visit the centre we are launching in Bethnal Green. I would gently say to the hon. Lady that she is part of the political party that propped up the Tories in government—this lot opposite—which led to some of the desperate situations we see across mental health today.

• 22 Jul 2025 · Topical Questions · Hansard source

  More

  The mess we inherited from the previous Government beggars belief, with 14 million adults with an unmet dental need, while for children between five and nine years old, the most common reason for hospital admission was to have their rotten teeth removed. This Government are determined to get NHS dentistry back on its feet. We are targeting the areas most in need, including rural areas, by delivering 700,000 additional urgent dental appointments, and reforming the dental contract. Our consultation is under way, and I encourage my hon. Friend to participate.

• 22 Jul 2025 · Topical Questions · Hansard source

  More

  One thing that I made clear to officials when I came into this post was that every penny that is allocated to NHS dentistry must be spent on NHS dentistry. We are in a crazy situation where demand for NHS dentistry is going through the roof, yet we have had underspends. That needs to stop. We will focus the spending on where it is most needed, including areas that are under-served, such as the hon. Gentleman’s constituency.

• 22 Jul 2025 · Topical Questions · Hansard source

  More

  Our 10-year plan will boost support for family carers via digital tools such as My Carer and include them in care planning and shared decision-making processes. We have raised the carer’s allowance earnings limit to £196 a week—the biggest increase since 1976—and we have launched the independent commission into adult social care, which will look at unpaid carers’ needs. The hon. Member raises an important point about respite care; I am chairing a cross-ministerial group on our carers strategy, and I would be happy to update him outside the Chamber.

• 11 Jul 2025 · Rare Cancers Bill · Hansard source

  More

  I am grateful to my hon. Friend the Member for Edinburgh South West (Dr Arthur) for bringing this Bill before the House, and I congratulate him on getting it to Report. Amendment 1 allows amendment 2 to be inserted into the Bill. Amendment 2 would require the Secretary of State, having carried out the review described in clause 1, to set out a timetable for implementing changes to the law recommended by the review. However, it would not be appropriate to presume the outcome of the review of orphan drug regulations that is outlined in clause 1. Amendment 2 presupposes that the review will recommend changing the law, and that there are changes the Secretary of State would be willing to support, following a legal consultation. That is not considered appropriate at this stage. Amendment 3 is unnecessarily restrictive, introducing wording that confines the review unnecessarily. We want to ensure that a thorough review is conducted, and my hon. Friend the Minister for Secondary Care will be working with her officials to ensure that that happens. For amendment 4, the three-year timeframe to prepare and publish the review and the necessary resourcing requirements have been discussed with officials in my Department and at the Medicines and Healthcare products Regulatory Agency. I remind Members that the text in the Bill reflects the statutory deadline, but we will endeavour to publish a report ahead of the three-year timeframe, which has been put forward to be consistent with the MHRA’s overall workplan. On amendment 5, there are different definitions of a rare cancer, and we worked with my hon. Friend the Member for Edinburgh South West to agree the definition in the Bill as a cancer that affects not more than one in 2,000 people in the UK. However, a level of discretion for the Secretary of State is required over what falls within that definition, since the facts underlying and the data on diagnoses are constantly changing. The amendment would make it difficult to implement the clause in practical and operational terms. Amendment 6 would remove the ability of the Secretary of State to exercise discretion as to how their duty would be discharged. This is not considered appropriate, since it makes the operation of clause 2 less workable in practice, and would lack the Government’s assessment of what in all the circumstances would be the most appropriate manner of implementation. Amendment 7 would introduce a specific timeframe—just six months—to allow the appointment of the specialty lead. Although I agree that we will need to appoint the specialty lead promptly, introducing a statutory timeframe is not considered workable for practical reasons. There could be unforeseen delays; for example, recruitment processes might delay the appointment beyond six months. On amendment 8, as mentioned previously there are different definitions for a rare cancer. That is because the data on cancer diagnoses is constantly changing, and decisions on whether the criteria for a rare cancer are met will inevitably involve an element of judgment. The amendment would make it difficult to implement the clause in practical and operational terms. I turn finally to amendment 9. It is essential that information relating to people’s health and care is shared appropriately, lawfully, and in line with their reasonable expectations. Amendment 9 would remove the provision confirming that any sharing of information pursuant to the powers created by the Bill, and under NHS England’s existing powers, must be in accordance with data protection legislation. That includes compliance with key principles such as lawfulness and fairness. That layer of assurance is essential for the protection of patients, and clause 3 is a standard provision that makes that explicit. For those reasons, I ask the hon. Member for Christchurch (Sir Christopher Chope) to withdraw all nine of his amendments.

• 11 Jul 2025 · Rare Cancers Bill · Hansard source

  More

  I again congratulate my hon. Friend the Member for Edinburgh South West (Dr Arthur). It is a huge achievement for a colleague who has only served in this place for just over a year to have got a Bill this far. I thank hon. Members across the House who have spoken in the debate so powerfully and movingly, as well as all those who sat on the Bill Committee. We welcome effective scrutiny from Committees, and we value the vital role that Parliament plays in holding us to account. I pay tribute to the charities that are backing the Bill, many of which we are engaging with on the development of our national cancer plan. The Government want to go further for everyone diagnosed with a rare cancer, and the Bill will act to incentivise the recruitment to, oversight of and accessibility of rare cancer research, so that NHS patients are at the front of the queue for cutting-edge treatments. We know the benefits of embedding clinical research across the NHS and beyond. It leads to better care for patients and more opportunities for our workforce, and it provides a huge economic benefit for our health and care system. On 3 July, we published our 10-year health plan, which sets out the vision to distribute power to patients and revitalise our NHS, making it fit for the future. The plan will deliver three shifts in care to ensure that the health service can tackle the problems of today and tomorrow, all of which will be key to tackling cancer. Through the 10-year health plan we will ensure that patients receive the most cutting-edge treatment, and that everyone can search for research studies through the Be Part of Research service on the NHS app. That is why we welcome the Bill, which is aligned with our commitments. It raises the profile of rare cancer research, ensures our international regulatory competitiveness, and allows rare cancer patients to be contacted as quickly as possible about research opportunities. That innovation will be delivered through Be Part of Research, our flagship research registry delivered through the National Institute for Health and Care Research, which allows people from all walks of life to sign up and get involved in research across the UK. I urge everyone watching this debate, and Members in the Chamber who are interested, to sign up to Be Part of Research, and see what research opportunities are relevant to them. The Government want to give all rare cancer patients access to clinical trials, and greater choice and control over their healthcare. That is why we are delighted to pledge Government support for the Bill. As we set out in our manifesto, the Government are committed to ensuring that the clinical research ecosystem is more efficient, competitive and accessible, and the provisions in the Bill align with that. We want the UK to lead the world in this space as the prime destination for clinical research. The Government also want to give patients greater choice and control over their healthcare, and rare cancer patients should have access to vital research if they choose to. Once again, I thank my hon. Friend the Member for Edinburgh South West for presenting the Bill, and those Members who served on the Committee. I pay tribute to all the charities that are backing this important Bill. The Government support the Bill, and I look forward to working with Members across the House to improve outcomes for rare cancer patients across our country.

• 9 Jul 2025 · Glaucoma Awareness · Hansard source

  More

  I thank the hon. Gentleman for that intervention. In our manifesto, we of course set a target of 2 million additional appointments within the first year of a Labour Government, and we have delivered 4 million. The key thing is to ensure that we get people off the waiting list. Regarding the figure of 5 million that he referred to, I do not know whether there was more activity, but somehow it was not helping to reduce the waiting lists, because we saw the waiting lists rise consistently. The key metric is, of course, the waiting list being reduced, and I am very pleased to say that, when it comes to eyecare, a reduction of 24,000 patients has been delivered since July 2024. That marks a vital first step to delivering on the commitment that 92% of patients will wait no longer than 18 weeks from referral to consultant-led treatment, in line with the NHS constitutional standard, by March 2029. In addition to making progress on reducing waiting lists, we recognise the challenges facing ophthalmology services as one of the largest out-patient specialities in the NHS, and demand is set only to increase due to the ageing population. NHS England has worked with 11 ICBs to test a new way of delivering eyecare that aims to reduce pressure on hospital eye services. The new model is emblematic of our shift from analogue to digital, as it uses IT connectivity between primary and secondary care services to improve the referral and triage of patients, with patient data and images being assessed by clinicians to determine whether patients need a secondary care appointment. It is called the single point of access approach. The SPOA approach reduces unnecessary hospital appointments, reduces the time from referral to treatment and allows more patients to be managed in the community. The ICBs testing the SPOA model have consistently demonstrated a reduction in unnecessary secondary care appointments and a significant reduction in wait times, both in time to treatment and to follow-up care. NHS England is continuing to share the learning from the accelerator sites for the SPOA with ICBs. I want to see more ICBs adopting that approach for the benefit of patients, including those with suspected or diagnosed glaucoma. I believe that the SPOA has tremendous unharnessed potential and is a great example of how, by harnessing technology, we can improve the way the overall system works and facilitate the interface between primary and secondary care that we know is at the heart of so many of the challenges that we face across our health and care system. Looking at the shift from sickness to prevention, although glaucoma cannot be cured, if it is caught early, treatment can prevent sight loss. The National Institute for Health and Care Excellence plays a crucial role in evaluating new medicines, medical devices and other technologies to determine their clinical and cost-effectiveness before recommending them for NHS use. NICE has published guidelines on the diagnosis and management of glaucoma. It has also published guidance on interventional procedures that provide recommendations on whether glaucoma-related procedures are safe and effective enough for wider use in the NHS. A number of treatments are available for glaucoma, including eye drops, laser treatment or surgery, aiming to lower eye pressure and prevent or slow down optic nerve damage to reduce the risk of sight loss. Although there are treatments for glaucoma, it is a lifelong condition that requires regular monitoring. Historically, that has taken place in hospital but, in line with our aim to move more care from hospital to the community, there is no reason why, when clinically appropriate, that activity could not be undertaken outside of hospital. We know that some ICBs are already commissioning glaucoma monitoring in the community. We must also recognise that, if diagnosed late, glaucoma can sadly lead to irreversible sight loss. The hon. Member for Leicester South spoke passionately from clinical experience about the significant impact that sight loss can have on an individual. Emotional support is therefore vital. There are various resources that aim to improve the support, including mental health support, available to patients through their sight loss journey. That includes NHS England’s patient support toolkit for commissioners and providers and the RNIB’s 2023 patient support pathway. Those sit alongside talking therapies and psychological therapies, which are widely available and to which patients can refer themselves directly. We are also taking steps to update the form for certificates of visual impairment to improve the signposting of patients to local support services. Finally, I recognise the potential for research and innovation to help us to understand sight loss and to develop new treatments, including for glaucoma. The Department for Health and Social Care funds eyecare research through the National Institute for Health and Care Research. NIHR infrastructure funding provides investment in research expertise, specialist facilities, a research workforce and services that help to support and deliver research studies through a range of clinical areas, including eyecare research. That includes the NIHR Moorfields Biomedical Research Centre, which received funding of almost £22 million for five years from 1 December 2022, and is solely dedicated to eyecare research. The Moorfields BRC has been key in advancing research through a range of studies and clinical innovations in the glaucoma field. One of its flagship projects is a large-scale trial investigating the use of vitamin B3 to slow the progression of glaucoma. Recruitment for that study is ongoing at multiple sites across England. As I have set out, the Government take glaucoma extremely seriously. Community optometry continues to play a vital role in preventing glaucoma. We are committed to improving eyecare services and patient outcomes, to reducing avoidable sight loss and, in particular, to harnessing the power of technology to drive those improvements forward. I also hope that this debate has further helped to raise awareness and may prompt a few more sight tests as a result. Once again, I congratulate the hon. Member for Leicester South on securing this important debate.